Publications by authors named "E Bonnemaison"
Article Synopsis
- The study aimed to assess the long-term effects of using a hybrid closed loop (HCL) system on glucose levels and body mass index (BMI) in children with type 1 diabetes during puberty.* -
- Over 30 months, data showed that improvements in HbA1c levels were maintained and BMI scores remained stable in participants, with no severe hypoglycemic events and only one unrelated ketoacidosis case.* -
- Findings suggest that prolonged HCL usage can help manage glucose control during puberty without negatively affecting BMI in children with type 1 diabetes.*
Article Synopsis
- Most insulin catheters are changed every 3 days, and this study evaluates how these changes affect glucose control in type 1 diabetes patients using two different insulin delivery methods: open-loop (OL) and automated insulin delivery (AID).
- Researchers analyzed data from 134 patients who used the Tandem t:slim x2 insulin pump and Dexcom G6 sensor over a 3-month period, focusing on the percentage of time their glucose levels were above 180 mg/dL (%TAR180) on the day of the catheter change and the following two days.
- Results indicated that there was a significant increase in time spent in hyperglycemia on the day of catheter change for both OL and AID modes,
12-Month Real-Life Efficacy of the MiniMed 780G Advanced Closed-Loop System in Patients Living with Type 1 Diabetes: A French Observational, Retrospective, Multicentric Study.
Sandrine Lablanche Johanna Delagenière Manon Jalbert Emmanuel Sonnet Muriel Benichou Elisabeth Bonnemaison
Diabetes Technol Ther
June 2024
Article Synopsis
- * Results showed significant improvements in key measures: time in range (TIR) increased by 9.1%, HbA1c decreased by 0.5%, and notable reductions in time spent below and above target levels.
- * The majority of patients (92.7%) continued using the system, and more achieved glycemic goals after one year, although there were some reported cases of severe hypoglycemia and ketoacidosis.
Article Synopsis
- * It analyzed data from 60 children over four treatment phases, noting the percentage of time their glucose levels stayed in the target range while considering missed boluses.
- * Results indicate that HCL therapy consistently improved glycemic control compared to SAP, even when meal insulin was missed, suggesting HCL may be the better choice for managing diabetes in children.